Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait.
Adult
COVID-19
/ diagnosis
Female
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical
/ statistics & numerical data
Kuwait
Maternal Welfare
/ statistics & numerical data
Pandemics
/ statistics & numerical data
Pregnancy
Pregnancy Complications, Infectious
/ diagnosis
Pregnancy Outcome
Prenatal Diagnosis
/ statistics & numerical data
Retrospective Studies
Young Adult
COVID-19
Clinical features
Neonates
Pregnant women
SARS-CoV-2
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
02 Dec 2020
02 Dec 2020
Historique:
received:
11
08
2020
accepted:
26
11
2020
entrez:
3
12
2020
pubmed:
4
12
2020
medline:
15
12
2020
Statut:
epublish
Résumé
The effect of SARS-CoV-2 infection in pregnant women and newborns is incompletely understood. Preliminary data shows a rather fluctuating course of the disease from asymptomatic or mild symptoms to maternal death. However, it is not clear whether the disease increases the risk of pregnancy-related complications. The aim of the study is to describe the maternal and neonatal clinical characteristics and outcome of pregnancies with SARS-CoV-2 infection. In this retrospective national-based study, we analyzed the medical records of all pregnant women infected with SARS-CoV-2 and their neonates who were admitted to New-Jahra Hospital (NJH), Kuwait, between March 15th 2020 and May 31st 2020. During the study period and as part of the public health measures, a total of 185 pregnant women infected with SARS-CoV-2, regardless of symptoms, were hospitalized at NJH, and were included. Maternal and neonatal clinical manifestations, laboratory tests and treatments were collected. The outcomes of pregnancies included miscarriage, intrauterine fetal death (IUFD), preterm birth and live birth were assessed until the end date of the outcomes follow-up (November 10th 2020). A total of 185 pregnant women infected with SARS-CoV-2 were enrolled with a median age of 31 years (interquartile range, IQR: 27.5-34), and median gestational age at diagnosis of SARS-CoV2 infection was 29 weeks (IQR: 18-34). The majority (88%) of these women had mild symptoms, with fever (58%) being the most common presenting symptom followed by cough (50.6%). At the time of the analysis, out of the 185, 3 (1.6%) of the pregnant women had a miscarriage, 1 (0.54%) had IUFD which was not related to COVID-19, 16 (8.6%) had ongoing pregnancies and 165 (89%) had a live birth. Only 2 (1.1%) of these women developed severe pneumonia and required intensive care. A total of 167 neonates with two sets of twins were born with median gestational age at birth was 38 (IQR: 36-39) weeks. Most of the neonates were asymptomatic, and only 2 of them tested positive on day 5 by nasopharyngeal swab testing. In this national-based study, most of the pregnant women infected with SARS-CoV-2 showed mild symptoms. Although mother-to-child vertical transmission of SARS-CoV-2 is possible, COVID-19 infection during pregnancy may not lead to unfavorable maternal and neonatal outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The effect of SARS-CoV-2 infection in pregnant women and newborns is incompletely understood. Preliminary data shows a rather fluctuating course of the disease from asymptomatic or mild symptoms to maternal death. However, it is not clear whether the disease increases the risk of pregnancy-related complications. The aim of the study is to describe the maternal and neonatal clinical characteristics and outcome of pregnancies with SARS-CoV-2 infection.
METHODS
METHODS
In this retrospective national-based study, we analyzed the medical records of all pregnant women infected with SARS-CoV-2 and their neonates who were admitted to New-Jahra Hospital (NJH), Kuwait, between March 15th 2020 and May 31st 2020. During the study period and as part of the public health measures, a total of 185 pregnant women infected with SARS-CoV-2, regardless of symptoms, were hospitalized at NJH, and were included. Maternal and neonatal clinical manifestations, laboratory tests and treatments were collected. The outcomes of pregnancies included miscarriage, intrauterine fetal death (IUFD), preterm birth and live birth were assessed until the end date of the outcomes follow-up (November 10th 2020).
RESULTS
RESULTS
A total of 185 pregnant women infected with SARS-CoV-2 were enrolled with a median age of 31 years (interquartile range, IQR: 27.5-34), and median gestational age at diagnosis of SARS-CoV2 infection was 29 weeks (IQR: 18-34). The majority (88%) of these women had mild symptoms, with fever (58%) being the most common presenting symptom followed by cough (50.6%). At the time of the analysis, out of the 185, 3 (1.6%) of the pregnant women had a miscarriage, 1 (0.54%) had IUFD which was not related to COVID-19, 16 (8.6%) had ongoing pregnancies and 165 (89%) had a live birth. Only 2 (1.1%) of these women developed severe pneumonia and required intensive care. A total of 167 neonates with two sets of twins were born with median gestational age at birth was 38 (IQR: 36-39) weeks. Most of the neonates were asymptomatic, and only 2 of them tested positive on day 5 by nasopharyngeal swab testing.
CONCLUSIONS
CONCLUSIONS
In this national-based study, most of the pregnant women infected with SARS-CoV-2 showed mild symptoms. Although mother-to-child vertical transmission of SARS-CoV-2 is possible, COVID-19 infection during pregnancy may not lead to unfavorable maternal and neonatal outcomes.
Identifiants
pubmed: 33267785
doi: 10.1186/s12884-020-03461-2
pii: 10.1186/s12884-020-03461-2
pmc: PMC7709095
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
754Références
J Infect. 2020 Mar 4;:
pubmed: 32145216
Zhonghua Fu Chan Ke Za Zhi. 2020 Mar 25;55(3):166-171
pubmed: 32145714
J Microbiol Immunol Infect. 2019 Jun;52(3):501-503
pubmed: 29907538
BMJ. 2010 Mar 18;340:c1279
pubmed: 20299694
JAMA. 2020 May 12;323(18):1848-1849
pubmed: 32215589
Am J Obstet Gynecol MFM. 2020 May;2(2):100111
pubmed: 32518902
Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27
pubmed: 32430957
Acta Obstet Gynecol Scand. 2020 May;99(5):565-568
pubmed: 32277845
Arch Pathol Lab Med. 2020 Oct 1;144(10):1217-1222
pubmed: 32422078
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14
pubmed: 32335053
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
Viruses. 2020 Feb 10;12(2):
pubmed: 32050635
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
Ultrasound Obstet Gynecol. 2020 May;55(5):586-592
pubmed: 32180292
N Engl J Med. 2020 Jun 18;382(25):e100
pubmed: 32302077
Am J Reprod Immunol. 2010 Jun;63(6):425-33
pubmed: 20367629
Breastfeed Med. 2020 May;15(5):351-352
pubmed: 32271625
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581
Am J Perinatol. 2020 Aug;37(10):1070-1073
pubmed: 32396949
Best Pract Res Clin Haematol. 2003 Jun;16(2):153-68
pubmed: 12763484
Arch Acad Emerg Med. 2020 Apr 15;8(1):e49
pubmed: 32440660
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
J Med Virol. 2020 Jul;92(7):731-739
pubmed: 32219871
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
Clin Infect Dis. 2020 Mar 17;:
pubmed: 32182347
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA Pediatr. 2020 Jul 1;174(7):722-725
pubmed: 32215598
Clin Microbiol Rev. 2014 Jan;27(1):21-47
pubmed: 24396135
Am J Obstet Gynecol MFM. 2020 May;2(2):100113
pubmed: 32363336
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
PLoS One. 2020 Jun 4;15(6):e0234187
pubmed: 32497090
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829
pubmed: 32259279
JAMA. 2010 Apr 21;303(15):1517-25
pubmed: 20407061
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100134
pubmed: 32391519
J Clin Virol. 2020 Jun;127:104356
pubmed: 32302955
Lancet. 2009 Aug 8;374(9688):451-8
pubmed: 19643469
Am J Obstet Gynecol. 2020 Dec;223(6):911.e1-911.e14
pubmed: 32439389